Treat All versus targeted strategies to select HBV-infected people for antiviral therapy in The Gambia, west Africa: a cost-effectiveness analysis. (2024)
Attributed to:
MRC Centre for Global Infectious Disease Analysis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2214-109x(23)00467-9
PubMed Identifier: 38097300
Publication URI: http://europepmc.org/abstract/MED/38097300
Type: Journal Article/Review
Volume: 12
Parent Publication: The Lancet. Global health
Issue: 1
ISSN: 2214-109X